- Disease: Acute SARS-CoV-2, Avian Influenza, Influenza, Post-COVID-19
- Study type: Adaptive Platform Trial
- Study aim: To evaluate treatments for community acquired pneumonia in the hospital setting
- Number of participants enrolled: 8442
- Study enrolling from
Study Data
- Adults
- Paediatric
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Post-COVID-19
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Immnunomodulator
- Corticosteroid
- Baloxavir
- Oseltamivir
External Links
Other information
Funders:
- Horizon 2020
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to